NCT-10001

N/A

Report date: 2025/01/26 18:13:49
NME

Base Information

Drug NameNCT-10001
Drug Alias NameNCT-10001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor alpha-2 modulatorsGamma-aminobutyric acid A receptor alpha-3 modulators
TargetsGamma-aminobutyric acid A receptor alpha-2Gamma-aminobutyric acid A receptor alpha-3
Therapy Area/IndicationsAnxiety DisordersPainEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeurocycle Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesNeurocycle Therapeutics
Inactive CompaniesN/A
Active IndicationsAnxiety DisordersPainEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A